Home / Stocks / XENE

XENE insider trading

Xenon Pharmaceuticals Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
0
Bought · 24 mo
$0
Buys · last 90 days
0 · $0
Most recent buy
—

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-03-11MORTIMER IAN
PRESIDENT & CEO
Sold245,000$60.36$14.8M
2026-01-02MORTIMER IAN
PRESIDENT & CEO
Sold37,938$44.40$1.7M
2025-10-01MORTIMER IAN
PRESIDENT, CEO & INTERIM CFO
Sold25,000$40.16$1.0M

See XENE on the chart

Every insider buy and sell for XENE plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.